BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

HK Pharmaceuticals, Inc. Obtains Patent For Combinatorial Ribozyme Library Technology


10/19/2005 5:11:11 PM

HK Pharmaceuticals™, Inc. today announced that it has obtained a patent from the Canadian Patent Office (CA 2319112) entitled "Use of Ribozymes for Functionating Genes." This core patent covers processes for combinatorial ribozyme libraries and technologies to turn off principal pathways within cells, or inactivate genes, to visualize genetic and phenotypic attributes of selected genes coding for proteins of therapeutic interest. A corresponding US patent has been allowed and is expected to be issued soon. HK Pharmaceuticals’ method uses ribozymes, molecules of RNA with enzyme-like properties, to cleave specific messenger RNA sequences to silence the activity of selected genes resulting in reduced or eliminated expression of the respective proteins. Because many diseases are caused by the activity of specific genes, the ability to silence such genes selectively is a valuable tool for drug target validation, pathway mapping and the elucidation of a drug’s mechanism of action. The experiments can take as little as a few days compared to the several months it takes to knock out a single gene in mice.


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES